abstract |
PROBLEM TO BE SOLVED: To provide a novel therapeutic method for treating an autoimmune and inflammatory disease. More specifically, the present invention relates to the use of low doses of interleukin-2 for treating type I diabetes and other autoimmune and / or inflammatory diseases. [Selection diagram] None |